Public Reporting

In January 2015, Penn State Care Health Partners was selected to be an Accountable Care Organization (ACO) in the Medicare Share Savings Program (MSSP), a program sponsored by the Centers for Medicare and Medicaid Services (CMS). This page provides information regarding PSHCP’s participation in that program.

ACO Name and Location

Penn State Health Care Partners
2500 Bernville Rd
Reading, PA 19605

ACO Primary Contact

Andrew Barna
Penn State Health Care Partners
2500 Bernville Rd
Reading, PA 19605
844-275-2128
abarna@hmc.psu.edu

Hours of Operation

Monday through Friday
8am-5pm EST

ACO Participants

St. Joseph Medical Group
St. Joseph Regional Health Network *
Berks Cardiologists, LTD
Digestive Disease Associates, LTD
JM Winston Radiology Associates, Inc.
Wyomissing Optometric Center, Inc.
Timothy Malak
Integrated Medical Group, PC
Physicians' Alliance, LTD.
The Milton S. Hershey Medical Center *
The Milton S. Hershey Medical Center Physician Group
Berks Pathology Associates, Inc.
Premier Foot & Ankle Associates, PC

ACO participants involved in a joint venture are identified by the * next to their names on the Participant List

ACO Governing Body

Board of Managers:

Susan Promes, M.D., Voting Member and Chair, ACO Participant, The Milton S. Hershey Medical Center

John Morahan, Voting Member and Vice Chair, ACO Participant, St. Joseph Regional Health Network

Christopher Newman, M.D., Voting Member and Secretary/Treasurer, ACO Participant, St. Joseph Regional Health Network

William Bird, D.O., Voting Member, ACO Participant, The Milton S. Hershey Medical Center

Alan Brechbill, Voting Member, ACO Participant, The Milton S. Hershey Medical Center

Anthony Cardell, M.D., Voting Member, ACO Participant, Mount Nittany Health

Peter Dillon, M.D., Voting Member, ACO Participant, The Milton S. Hershey Medical Center

Tipton Ford, Voting Member, ACO Participant, The Milton S. Hershey Medical Center

Mary Hahn, Voting Member, ACO Participant, St. Joseph Regional Health Network

Robert Hippert, D.O., Voting Member, ACO Participant, St. Joseph Regional Health Network

Sharon Strohecker, Voting Member, ACO Participant, St. Joseph Regional Health Network

Charles Mershon, M.D., Voting Member, ACO Participant, Physicians’ Alliance Ltd

Ronald Polinsky, M.D., Voting Member, ACO Participant, St. Joseph Regional Health Network

Todd Stanton, Voting Member, ACO Participant, The Milton S. Hershey Medical Center

Steve Massini, Voting Member, ACO Participant, The Milton S. Hershey Medical Center

Lloyd Wolf, D.O., Voting Member, ACO Participant, St. Joseph Regional Health Network

Ken Laird, Voting Member, Medicare Beneficiary Representative

Key ACO Clinical and Administrative Leadership

Administrative Director: Andrew Barna
Chief Medical Officer: William Bird, D.O.
Compliance Official: Kimberly Lansford
Medical Director for Care Management: William Curry, M.D.

ACO Committees and Committee Leadership

Clinical Operations Committee:

William Curry, M.D., Co-Chair
Kimberly Wolf, D.O., Co-Chair

Finance Committee:

Robert Hippert, D.O., Co-Chair
Mack Ruffin, M.D., Co-Chair

Quality Committee:

William Bird, D.O., Co-Chair
Leif Christiansen, D.O., Co-Chair

State College Oversight Committee:

William Bird, D.O., Co-Chair
Anthony Cardell, M.D., Co-Chair

Types of ACO participants, or combinations of participants, that formed the ACO: Partnership or joint venture arrangements between hospitals and ACO professionals

Amount of Shared Savings / Losses:

  • Agreement period beginning 2015, Performance Year 2015: $0

How Shared Savings are distributed

  • Agreement period beginning 2015, Performance Year 2015
    • Proportion invested in infrastructure: 20%
    • Proportion of distribution to ACO participants: 80%

Payment Rule Waivers

No, our ACO does not utilize the SNF 3-Day Rule Waiver.

Quality Performance Results

 

2015 Quality Performance Results Table
Measure
Number
Measure Name 2015 Reporting Period
ACO
Performance
Rate
Mean
Performance Rate
(SSP-ACOs)
ACO #1 CAHPS: Getting Timely Care, Appointments, and Information 85.27 80.61
ACO #2 CAHPS: How Well Your Providers Communicate 93.44 92.65
ACO #3 CAHPS: Patients’ Rating of Provider 93.51 91.94
ACO #4 CAHPS: Access to Specialists 83.89 83.61
ACO #5 CAHPS: Health Promotion and Education 59.93 59.06
ACO #6 CAHPS: Shared Decision Making 78.88 75.17
ACO #7 CAHPS: Health Status/Functional Status 77.02 72.30
ACO #34 CAHPS: Stewardship of Patient Resources* 25.29 26.87
ACO #8 Risk Standardized, All Condition Readmission 14.72 14.86
ACO #35 Skilled Nursing Facility 30-Day All-Cause Readmission Measure (SNFRM)* 17.12 18.07
ACO #36 All-Cause Unplanned Admissions for Patients with Diabetes* 47.03 54.60
ACO #37 All-Cause Unplanned Admissions for Patients with Heart Failure* 76.26 76.96
ACO #38 All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions 60.35 62.92
ACO #9 Ambulatory Sensitive Condition Admissions: Chronic Obstructive Pulmonary Disease or Asthma in Older Adults (AHRQ Prevention Quality Indicator (PQI) #5) 1.07 1.11
ACO #10 Ambulatory Sensitive Conditions Admission: Heart Failure (AHRQ Prevention Quality Indicator (PQI) #8) 1.03 1.04
ACO #11 Percent of Primary Care Physicians who Successfully Meet Meaningful Use Requirements 97.20 76.22
ACO #39 Documentation of Current Medications in the Medical Record* 98.13 84.07
ACO #13 Falls: Screening for Future Fall Risk 65.04 56.46
ACO #14 Preventive Care and Screening: Influenza Immunization 55.00 62.03
ACO #15 Pneumonia Vaccination Status for Older Adults 79.44 63.73
ACO #16 Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-up 58.06 71.15
ACO #17 Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention 92.77 90.16
ACO #18 Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan 39.27 45.25
ACO #19 Colorectal Cancer Screening 63.78 60.06
ACO #20 Breast Cancer Screening 59.27 65.67
ACO #21 Preventive Care and Screening: Screening for High Blood Pressure and Follow-up Documented 36.29 70.04
ACO #40 Depression Remission at Twelve Months* N/A N/A
ACO #27 Diabetes Mellitus: Hemoglobin A1c Poor Control 22.98 20.38
ACO #41 Diabetes: Eye Exam* 55.24 41.05
ACO #28 Hypertension: Controlling High Blood Pressure 68.95 69.62
ACO #30 Ischemic Vascular Disease: Use of Aspirin of Another Antithrombotic 87.50 83.82
ACO #31 Heart Failure: Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD) 87.57 87.22
ACO #33 Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy - for patients with CAD and Diabetes or Left Ventricular Systolic Dysfunction (LVEF<40%) 77.72 77.73
CAHPS = Consumer Assessment of Healthcare Providers and Systems, PQI = Prevention Quality Indicator, LVSD = left ventricular systolic dysfunction, ACE = angiotensin-converting enzyme, ARB = angiotensin receptor blocker, CAD = coronary artery disease.
* = Measure required beginning Reporting Year 2015
N/A = Reporting on the depression remission measure is not required for 2015, as indicated by N/A